Engraftment of chronic myelomonocytic leukemia cells in immunocompromised mice supports disease dependency on cytokines

about

Using patient-derived iPSCs to develop humanized mouse models for chronic myelomonocytic leukemia and therapeutic drug identification, including liposomal clodronate

P2860

Q58116145-969E6458-04F4-4F74-987D-69DD39947526

P2860

Engraftment of chronic myelomonocytic leukemia cells in immunocompromised mice supports disease dependency on cytokines

Item

http://www.wikidata.org/entity/Q58125348

description

scientific article published on 13 June 2017

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована в червні 2017

@uk

name

Engraftment of chronic myelomo ...... isease dependency on cytokines

@en

Engraftment of chronic myelomo ...... isease dependency on cytokines

@nl

type

Item

label

Engraftment of chronic myelomo ...... isease dependency on cytokines

@en

Engraftment of chronic myelomo ...... isease dependency on cytokines

@nl

prefLabel

Engraftment of chronic myelomo ...... isease dependency on cytokines

@en

Engraftment of chronic myelomo ...... isease dependency on cytokines

@nl

P1476

Engraftment of chronic myelomo ...... isease dependency on cytokines

@en

P2093

Chloe Jego

http://www.w3.org/2001/XMLSchema#string

Eric Solary

http://www.w3.org/2001/XMLSchema#string

Liang He

http://www.w3.org/2001/XMLSchema#string

M'boyba Khadija Diop

http://www.w3.org/2001/XMLSchema#string

Margot Morabito

http://www.w3.org/2001/XMLSchema#string

Valérie Lapierre

http://www.w3.org/2001/XMLSchema#string

Yanyan Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia.

A Multi-Institution Phase I Trial of Ruxolitinib in Patients with Chronic Myelomonocytic Leukemia (CMML)

MPL expression on AML blasts predicts peripheral blood neutropenia and thrombocytopenia.

GM-CSF-dependent pSTAT5 sensitivity is a feature with therapeutic potential in chronic myelomonocytic leukemia.

Humanized mice in translational biomedical research.

Cytogenetic risk stratification in chronic myelomonocytic leukemia.

Development of human CD4+FoxP3+ regulatory T cells in human stem cell factor-, granulocyte-macrophage colony-stimulating factor-, and interleukin-3-expressing NOD-SCID IL2Rγ(null) humanized mice.

CXCR4 inhibitors selectively eliminate CXCR4-expressing human acute myeloid leukemia cells in NOG mouse model.

Mutation allele burden remains unchanged in chronic myelomonocytic leukaemia responding to hypomethylating agents.

Chronic myelomonocytic leukemia: 2016 update on diagnosis, risk stratification, and management.

P304

972-979

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOODADVANCES.2017004903

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Nathalie Droin

Fawzia Louache

C Willekens

Dorothée Selimoglu-Buet

Patrick Gonin

P577

2017-06-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29296739

http://www.w3.org/2001/XMLSchema#string

P921

leukemia

P932

5737594

http://www.w3.org/2001/XMLSchema#string